Corporate Office HQ

Biotechnology

Amgen Corporate Office

Amgen is a multinational biopharmaceutical company that produces drugs used to prevent infections in chemotherapy patients, treatment of rheumatoid arthritis, and many others.

Amgen was founded in 1983 as Applied Molecular Genetics. In 1986 the name of the company was changed to Amgen at the same time that it began trading on the NASDAQ.

In 1989 Amgen received FDA approval for Epogen, a treatment for Anemia that would prove to have wide-reaching applications for cancer and HIV patients and was the company’s first success.

In 1991 the company received approval for Neupogen for the prevention of infections in patients with compromised immune systems.

Today Amgen is the world’s largest independent biotechnology firm and uses cellular biology and medicinal chemistry to target cancers, kidney ailments, inflammatory disorders, and metabolic diseases. The company has extensive drug research and development programs.

Amgen trades publicly on the NASDAQ under the symbol AMGN, is a member of the S&P 500, has 20,000 employees, and had $18.96 billion in revenue in 2013.

Amgen

Amgen is a multinational biopharmaceutical company that produces drugs used to prevent infections in chemotherapy patients, treatment of rheumatoid arthritis, and many others.

Amgen was founded in 1983 as Applied Molecular Genetics. In 1986 the name of the company was changed to Amgen at the same time that it began trading on the NASDAQ.

In 1989 Amgen received FDA approval for Epogen, a treatment for Anemia that would prove to have wide-reaching applications for cancer and HIV patients and was the company’s first success.

History

In 1991 the company received approval for Neupogen for the prevention of infections in patients with compromised immune systems.

Today Amgen is the world’s largest independent biotechnology firm and uses cellular biology and medicinal chemistry to target cancers, kidney ailments, inflammatory disorders, and metabolic diseases. The company has extensive drug research and development programs.

Amgen trades publicly on the NASDAQ under the symbol AMGN, is a member of the S&P 500, has 20,000 employees, and had $18.96 billion in revenue in 2013.

Thermo Fisher Scientific Corporate Office

Thermo Fisher Scientific is the result of the 2006 merger of Thermo Electron and Fisher Scientific.

Thermo Electron was founded in 1956 by George Hatsopoulos and Peter Nomikos. The company focused on analytical laboratory products and had revenue  of $2 billion in 2004.

Fisher Scientific was founded in 1902 by Chester Fisher. The company focused on laboratory equipment, chemicals, supplies, and services for the fields of healthcare, research, safety, and education.

Thermo Fisher Scientific serves hundreds of thousands of customers worldwide in its key markets of health care and diagnostics, biotech and pharmaceutical, academic, government, and industrial and applied settings which includes environmental quality.

Thermo Fisher Scientific trades publicly on the New York Stock Exchange under the symbol TMO, is a member of the S&P 500, is #220 on the Fortune 500, has 50,000 employees, and $13.80 billion in revenue in 2013.

 

Thermo Fisher Scientific

Thermo Fisher Scientific is the result of the 2006 merger of Thermo Electron and Fisher Scientific.

Thermo Electron was founded in 1956 by George Hatsopoulos and Peter Nomikos. The company focused on analytical laboratory products and had revenue  of $2 billion in 2004.

Fisher Scientific was founded in 1902 by Chester Fisher. The company focused on laboratory equipment, chemicals, supplies, and services for the fields of healthcare, research, safety, and education.

History

Thermo Fisher Scientific serves hundreds of thousands of customers worldwide in its key markets of health care and diagnostics, biotech and pharmaceutical, academic, government, and industrial and applied settings which includes environmental quality.

Thermo Fisher Scientific trades publicly on the New York Stock Exchange under the symbol TMO, is a member of the S&P 500, is #220 on the Fortune 500, has 50,000 employees, and $13.80 billion in revenue in 2013.

 

Bunge Limited Corporate Office

Bunge Limited was founded in 1818 as Bunge y Born in Amsterdam. In 1884 they expanded to Argentina, in 1905 to Brazil, and later to the U.S.

The company built its first major grain handling facility in Minnesota in 1935, thus becoming an originator of grain in North America. In 1946 the company acquired grain elevators in the Midwest and in 1961 opened an export grain-handling elevator in Louisiana that connected its domestic grain operations to world markets.

During the 1970s and 1980s Bunge grew its product and operational diversity by acquiring and building grain origination, soy processing, and food products businesses throughout North and South America.

Bunge y Born officially changed its name in 1994 to Bunge International when the company incorporated in the Bahamas.

Up until 2001 Bunge was a privately held company that was owned by 180 shareholders, with the Bunge family having a controlling interest.

In 2001 when Bunge went public, the company had three main businesses: agribusiness, fertilizer, and food products.

Today Bunge Limited has worldwide distribution, 32,000 employees at 400 facilities in 40 countries, and had revenue of $58.74 billion in 2011.

Bunge Limited

Bunge Limited was founded in 1818 as Bunge y Born in Amsterdam. In 1884 they expanded to Argentina, in 1905 to Brazil, and later to the U.S.

The company built its first major grain handling facility in Minnesota in 1935, thus becoming an originator of grain in North America. In 1946 the company acquired grain elevators in the Midwest and in 1961 opened an export grain-handling elevator in Louisiana that connected its domestic grain operations to world markets.

During the 1970s and 1980s Bunge grew its product and operational diversity by acquiring and building grain origination, soy processing, and food products businesses throughout North and South America.

History

Bunge y Born officially changed its name in 1994 to Bunge International when the company incorporated in the Bahamas.

Up until 2001 Bunge was a privately held company that was owned by 180 shareholders, with the Bunge family having a controlling interest.

In 2001 when Bunge went public, the company had three main businesses: agribusiness, fertilizer, and food products.

Today Bunge Limited has worldwide distribution, 32,000 employees at 400 facilities in 40 countries, and had revenue of $58.74 billion in 2011.

Archer Daniels Midland Corporate Office

The Archer Daniels Midland Company (ADM) was founded in 1902 by George A. Archer and John W. Daniels as a linseed crushing business. From then until 1970, they added one profit source per decade to their business, including processing, milling, and specialty food ingredients.

In 1970 Dwayne Andreas became CEO and began the process of transforming the company into an industrial powerhouse. He was CEO until 1997, when he was succeeded by his nephew, G. Allen Andreas.

Today ADM’s products include additives for fuel, food, and ingredients. The company has 270 plants and 420 crop procurement facilities worldwide, where oilseeds and grains are processed into animal feed, food, beverage, nutraceutical, and industrial products.

ADM has heavily invested in ethanol, bioenergy, and biofuels.

ADM is part of the S&P 500, was  named the World’s Most Admired Food Company by Fortune in 2009, 2010, and 2011, has 30,000 employees, and had revenue of $89 billion in 2012.

 

Archer Daniels Midland

The Archer Daniels Midland Company (ADM) was founded in 1902 by George A. Archer and John W. Daniels as a linseed crushing business. From then until 1970, they added one profit source per decade to their business, including processing, milling, and specialty food ingredients.

In 1970 Dwayne Andreas became CEO and began the process of transforming the company into an industrial powerhouse. He was CEO until 1997, when he was succeeded by his nephew, G. Allen Andreas.

Today ADM’s products include additives for fuel, food, and ingredients. The company has 270 plants and 420 crop procurement facilities worldwide, where oilseeds and grains are processed into animal feed, food, beverage, nutraceutical, and industrial products.

History

ADM has heavily invested in ethanol, bioenergy, and biofuels.

ADM is part of the S&P 500, was  named the World’s Most Admired Food Company by Fortune in 2009, 2010, and 2011, has 30,000 employees, and had revenue of $89 billion in 2012.

 

Monsanto Corporate Office

Monsanto was founded in 1901 in St. Louis, Missouri by John Francis Queeny.  The company’s first product was an artificial sweetener that they sold to Coca-Cola.

In 1919, the company expanded to Europe through a partnership with Graesser’s Chemical Works.

In 1936, the company acquired Thomas & Hochwalt Laboratories.

In 1944, the company began producing DDT.

In 1946, the company developed All laundry detergent.  The sold the product to the Lever Brothers in 1957.

In 1968, Monsanto was the first company to mass produce LED lights.

In 1982, scientists from the company genetically modify the first plant.

In 1996, the company acquired Agracetus, a biotechnology company that had produced transgenic varieties of several crops.

In 2009, Forbes Magazine named Monsanto the “Company of the Year”.

Today, Monsanto is the world’s leading producer of genetically engineered seed.  The company also produces the herbicide RoundUp.

 

Monsanto

Monsanto was founded in 1901 in St. Louis, Missouri by John Francis Queeny.  The company’s first product was an artificial sweetener that they sold to Coca-Cola.

In 1919, the company expanded to Europe through a partnership with Graesser’s Chemical Works.

In 1936, the company acquired Thomas & Hochwalt Laboratories.

History

In 1944, the company began producing DDT.

In 1946, the company developed All laundry detergent.  The sold the product to the Lever Brothers in 1957.

In 1968, Monsanto was the first company to mass produce LED lights.

In 1982, scientists from the company genetically modify the first plant.

In 1996, the company acquired Agracetus, a biotechnology company that had produced transgenic varieties of several crops.

In 2009, Forbes Magazine named Monsanto the “Company of the Year”.

Today, Monsanto is the world’s leading producer of genetically engineered seed.  The company also produces the herbicide RoundUp.